Condition

Myeloma Multiple clinical trials and research

• 20Clinical trials
• 12Countries

Newest Myeloma Multiple clinical trials

All recruiting trials (20)

• BCD-248 plus daratumumab in relapsed or refractory multiple myeloma

  This study tests whether adding BCD-248 to daratumumab helps people with relapsed or refractory multiple myeloma who have had prior lines of therapy.

  Recruiting at 16 sites Phase 3 Biocad · Homyel and 15 other locations · NCT07742215

• Immune Fitness in Older Adults with Relapsed or Refractory Multiple Myeloma

  This study checks whether immune health before treatment can predict how well older adults with relapsed or refractory multiple myeloma respond to CAR-T or bispecific antibody therapies.

  Recruiting Jules Bordet Institute · Anderlecht, Brussels Capital and 2 other locations · NCT07674498

• Infectious complications in blood cancer patients treated with bispecific antibodies

  This study tests how often infections occur in adults with blood cancers who are being treated with bispecific antibodies.

  Recruiting at 2 sites Infanta Leonor University Hospital · Madrid, Madrid and 1 other locations · NCT07609576

• Mapping individual multiple myeloma biology to understand relapse and treatment resistance

  This project will test whether combining clinical records with whole-genome and RNA sequencing plus blood tumor markers in people with multiple myeloma can reveal features that explain relapse and treatment resistance.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Bo · NCT07582354

• Multi-omics testing for blood and bone marrow cancers

  This project will test a multi-omics lab approach on bone marrow, blood, biopsy and other fluid samples from people with suspected or known hematologic cancers to see if it can better characterize their disease.

  Recruiting Azienda Ospedaliero-Universitaria di Parma · Parma, PR · NCT07445438

• Anonymizing and combining past clinical, genetic, and imaging data from people with multiple myeloma to build AI prediction models.

  This project will try to use already-collected clinical, genetic, and imaging data from adults with multiple myeloma to build AI models that predict disease progression and treatment response, with no new visits or tests required.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna, Bo · NCT07283224

• e-Motion: Promoting Emotion Regulation for People Living with Chronic Cancer

  This pilot tests two emotion-regulation programs—a guided self-help program and a combined group plus guided self-help program—for people recently diagnosed with metastatic or other chronic cancers.

  Recruiting Université Libre de Bruxelles · Brussels, Anderlecht and 1 other locations · NCT07236021

• High-altitude stem cell and bone marrow transplant registry on the Qinghai-Tibet Plateau

  This project will collect clinical data and blood/bone marrow samples from people having hematopoietic stem cell transplants on the Qinghai‑Tibet Plateau to see how high altitude affects transplant outcomes and recovery.

  Recruiting Affiliated Hospital of Qinghai University · Xining, Qinghai · NCT07205523

• Daratumumab-hyaluronidase added to your myeloma treatment to see if it helps kidney function

  This trial tests whether adding daratumumab-hyaluronidase to the standard bortezomib and dexamethasone therapy improves kidney function in adults newly diagnosed with multiple myeloma and kidney failure.

  Recruiting Phase 2 Eastern Cooperative Oncology Group · Anchorage, Alaska · NCT07085728

• KLN-1010 gene therapy for relapsed or refractory multiple myeloma

  This Phase 1 trial will try KLN-1010, an in vivo CAR‑T gene therapy, to see if it is safe and can be given at a tolerable dose for people with relapsed or refractory multiple myeloma who have had at least three prior therapies.

  Recruiting at 11 sites Phase 1 Kelonia Therapeutics, Inc. · Duarte, California and 10 other locations · NCT07075185

• Using CAR-T cell therapy for treating relapsed and refractory blood cancers

  This study is testing a new CAR-T cell therapy to see if it can help people with tough-to-treat blood cancers like lymphoma and leukemia feel better.

  Recruiting Phase 1/2 Tianjin Medical University General Hospital · Tianjin, Tianjin Municipality · NCT06911710

• Observational study on immunotherapy for multiple myeloma in Norway

  This study looks at how well new immunotherapy treatments for multiple myeloma work and what side effects they may cause for patients in Norway.

  Recruiting St. Olavs Hospital · Arendal and 22 other locations · NCT06855121

• Using Riluzole to Help Breast Cancer Survivors with Cognitive Issues

  This study is testing if the medication riluzole can help breast cancer survivors who are having trouble with thinking and memory feel better.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT06580002

• Frequency of GBA and PSAP Gene Variants in Patients with MM or MGUS

  This study tests whether people with multiple myeloma or MGUS have certain variants in the GBA and PSAP genes.

  Recruiting University Hospital, Rouen · Rouen and 1 other locations · NCT06559033

• Comparing bortezomib-bendamustine-melphalan to melphalan for treating multiple myeloma

  This study is testing if a new treatment combining bortezomib, bendamustine, and melphalan can help people with relapsed multiple myeloma do better than the standard high-dose melphalan treatment.

  Recruiting Uppsala University · Uppsala · NCT06245629

• Using a connected scale to monitor weight and vitals during lymphoma and myeloma treatment

  This project will test whether daily use of a connected scale to track weight and heart rate at home can help people with lymphoma or multiple myeloma who are receiving chemotherapy.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT06133426

• Limited-duration treatment with teclistamab for multiple myeloma

  This study is testing if a short-term treatment with teclistamab can help people with multiple myeloma keep their positive response after standard therapy without needing to stay on treatment continuously.

  Recruiting at 5 sites Phase 2 Abramson Cancer Center at Penn Medicine · Little Rock, Arkansas and 4 other locations · NCT05932680

• Testing a new drug for patients with advanced multiple myeloma

  This study is testing a new drug called KTX-1001 to see if it is safe and effective for adults with advanced multiple myeloma who have not responded to other treatments.

  Recruiting at 26 sites Phase 1 K36 Therapeutics, Inc. · San Francisco, California and 28 other locations · NCT05651932

• Using belantamab mafodotin and lenalidomide for maintenance therapy after stem cell transplant in multiple myeloma patients

  This study is testing if a combination of two medications, belantamab mafodotin and lenalidomide, can help people with multiple myeloma stay healthy longer after their stem cell transplant by reducing the cancer in their bodies.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT05091372

• Comparing PET/CT imaging methods in multiple myeloma patients

  This study is testing whether a new type of PET/CT scan using amino acids gives better information than the standard FDG PET/CT scan for people with multiple myeloma who may need a stem cell transplant.

  Recruiting Oslo University Hospital · Oslo · NCT03966443

Related topics

Quick answers

How many Myeloma Multiple clinical trials are recruiting right now?

20, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 12 countries. The most sites are in United States (6 trials), Italy (3 trials), France (3 trials), China (2 trials), Spain (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 1: 2, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →